FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors

被引:0
作者
Higashi, T [1 ]
Tamaki, N
Torizuka, T
Nakamoto, Y
Sakahara, H
Kimura, T
Honda, T
Inokuma, T
Katsushima, S
Ohshio, G
Imamura, M
Konishi, J
机构
[1] Kyoto Univ, Fac Med, Dept Nucl Med, Sakyo Ku, Kyoto 60601, Japan
[2] Kyoto Univ, Fac Med, Dept Surg 1, Kyoto 606, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
关键词
pancreatic tumor; GLUT-1; expression; fluorodeoxyglucose PET; immunohistochemistry; cellularity;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We previously reported that grading of GLUT-1 glucose transporter expression was related closely to FDG accumulation in FDG PET in human cancers. But in this strong GLUT-1 expression group, there was an enormous range of standardized uptake values (SUVs) within them. Methods: To evaluate other factors determining the FDG PET uptake, FDG PET was performed in 36 preoperative patients (mean age 62.0 yr) suspected of having pancreatic tumors, including 33 malignant and 3 benign neoplastic tumors. FDG uptake at 50 min after injection of 185 MBq F-18-FDG with > 5 hr fasting condition was semiquantitatively analyzed as SUVs, The GLUT-1 expression was studied by immunohistochemistry of paraffin sections from these tumors after the operation using the antiGLUT-1 antibody. The number of tumor cells within a 5- x 5-mm square was counted manually using x200 magnification photographs and was graded immunohistochemically as strong, weak or negative. Results: In all 36 cases there were 3 cases of GLUT-1 negative, 8 of GLUT-1 weak positive and 25 of GLUT-1 strong positive. In all cases, the total number of tumor cells had no significant value for SUVs, Among 33 GLUT-1 positive cases, the number of GLUT-1 positive tumor cells correlated significantly with SUVs (p < 0.01). Only in 25 strong grade cases, the number of GLUT-I strong positive tumor cells had a more significant Value for SUVs (p < 0.005). Computational multivariate analysis using multiple regression for SUVs was performed evaluating the five variables as follows: tumor size, GLUT-1 immunohistochemical grading, number of total tumor cells, number of total GLUT-1 positive tumor cells and number of GLUT-1 strong positive cells. This analysis revealed that only the variable, the number of GLUT-1 strong positive cells, had a significant regression coefficient for SUVs (standard regression coefficient = 0.855, p < 0.0001). Conclusion: These data indicate that GLUT-1 expression plays an essential role in higher FDG accumulation in pancreatic tumor FDG PET, and the cellularity has a significant influence on SUVs only in the condition of GLUT-1 strong positive expression.
引用
收藏
页码:1727 / 1735
页数:9
相关论文
共 31 条
  • [1] F-18 FLUORODEOXYGLUCOSE PET IN-VIVO EVALUATION OF PANCREATIC GLUCOSE-METABOLISM FOR DETECTION OF PANCREATIC-CANCER
    BARES, R
    KLEVER, P
    HAUPTMANN, S
    HELLWIG, D
    FASS, J
    CREMERIUS, U
    SCHUMPELICK, V
    MITTERMAYER, C
    BULL, U
    [J]. RADIOLOGY, 1994, 192 (01) : 79 - 86
  • [2] TRANSFORMATION OF RAT FIBROBLASTS BY FSV RAPIDLY INCREASES GLUCOSE TRANSPORTER GENE-TRANSCRIPTION
    BIRNBAUM, MJ
    HASPEL, HC
    ROSEN, OM
    [J]. SCIENCE, 1987, 235 (4795) : 1495 - 1498
  • [3] BROWN RS, 1995, J NUCL MED, V36, P1854
  • [4] COOLEY WW, 1971, MULRTIVATIATE DATA A
  • [5] PATTERN OF GLUCOSE TRANSPORTER (GLUT-1) EXPRESSION IN EMBRYONIC BRAINS IS RELATED TO MATURATION OF BLOOD-BRAIN-BARRIER TIGHTNESS
    DERMIETZEL, R
    KRAUSE, D
    KREMER, M
    WANG, C
    STEVENSON, B
    [J]. DEVELOPMENTAL DYNAMICS, 1992, 193 (02) : 152 - 163
  • [6] HAWKINS RA, 1991, J NUCL MED, V32, P1555
  • [7] Hermanek P., 1987, TNM Classification of Malignant Tumors, V4th edn
  • [8] HIGASHI K, 1993, J NUCL MED, V34, P414
  • [9] Higashi T, 1997, J NUCL MED, V38, P1337
  • [10] INOKUMA T, 1995, J NUCL MED, V36, P229